Drug Profile
Research programme: Hedgehog cell-signaling pathway inhibitors - Nexigen
Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Nexigen
- Class Peptides
- Mechanism of Action Hedgehog cell-signalling pathway inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Cancer in Germany (Parenteral)
- 02 Aug 2016 Early research in Cancer in Germany (Parenteral)